HYVO Trademark

Trademark Overview

On Monday, February 13, 2023, a trademark application was filed for HYVO with the United States Patent and Trademark Office. The USPTO has given the HYVO trademark a serial number of 97792725. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 18, 2025. This trademark is owned by argenx B.V.. The HYVO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune diseases and disorders
hyvo

General Information

Serial Number97792725
Word MarkHYVO
Filing DateMonday, February 13, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, February 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 18, 2025

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 2, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party Nameargenx B.V.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressZwijnaarde B-9052
BE
Party Nameargenx B.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZwijnaarde B-9052
BE

Trademark Events

Event DateEvent Description
Saturday, June 3, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, August 9, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, January 5, 2024ASSIGNED TO LIE
Thursday, February 16, 2023NEW APPLICATION ENTERED
Thursday, March 2, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 4, 2023ASSIGNED TO EXAMINER
Saturday, June 3, 2023SUSPENSION LETTER WRITTEN
Saturday, June 3, 2023LETTER OF SUSPENSION E-MAILED
Friday, January 5, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 5, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 3, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 13, 2024SUSPENSION LETTER WRITTEN
Tuesday, February 13, 2024LETTER OF SUSPENSION E-MAILED
Tuesday, February 13, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, September 3, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 3, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, January 14, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, January 27, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 12, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 18, 2025PUBLISHED FOR OPPOSITION
Tuesday, February 18, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

hyvo diseases disorders autoimmune treatment preparations pharmaceutical